Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard
Despite the widely accepted use of prostate specific antigen (PSA) as a marker of prostate cancer, this molecule has not yet been completely characterized. Past studies have well established, however, using both amino acid and cDNA sequencing techniques, that PSA contains 237 amino acids, with a mol...
Saved in:
Published in | The Prostate Vol. 27; no. 4; p. 187 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.10.1995
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Despite the widely accepted use of prostate specific antigen (PSA) as a marker of prostate cancer, this molecule has not yet been completely characterized. Past studies have well established, however, using both amino acid and cDNA sequencing techniques, that PSA contains 237 amino acids, with a molecular mass of 26,079 Da for the peptide moiety of the molecule. The present study reports analysis of this protein by ion spray mass spectrometry (ISMS) and analysis of its carbohydrate moiety by NMR spectroscopy. The predominant PSA molecular species detected by ISMS was at relative molecular mass (M(r)) of 28,430, indicating that PSA contains a carbohydrate residue of M(r) 2,351, for a total percentage of carbohydrate of 8.3%. Analysis of PSA by SDS-PAGE, however, showed a M(r) of 32,000 to 33,000, suggesting an overestimation of the molecular weight by the latter technique. The complete primary structure of the PSA carbohydrate chain was determined by NMR spectroscopy in combination with carbohydrate composition analysis. The experimentally determined carbohydrate content of PSA confirms that only one N-glycosylation site is occupied in the protein. The proposed carbohydrate structure is a diantennary N-linked oligosaccharide of the N-acetyllactosamine type, with a sialic acid group at the end of each of the two branches. In addition, our data indicate that approximately 70% of the PSA molecules contain a fucose group in the core chitobiose moiety. The calculated molecular weight of this carbohydrate structure (M(r) 2,351.8) is in excellent agreement with the predicted molecular weight of the carbohydrate group, based on the M(r) 28,430 for PSA measured by ion spray mass spectrometry and M(r) 26,079 calculated from the consensus sequence for the peptide portion of the molecule. ISMS of PSA is thus proposed as a convenient and reliable method of quality control, an indispensible step towards international standardization of this very important tumor marker for detection and monitoring of prostatic diseases, especially prostate cancer. |
---|---|
AbstractList | Despite the widely accepted use of prostate specific antigen (PSA) as a marker of prostate cancer, this molecule has not yet been completely characterized. Past studies have well established, however, using both amino acid and cDNA sequencing techniques, that PSA contains 237 amino acids, with a molecular mass of 26,079 Da for the peptide moiety of the molecule. The present study reports analysis of this protein by ion spray mass spectrometry (ISMS) and analysis of its carbohydrate moiety by NMR spectroscopy. The predominant PSA molecular species detected by ISMS was at relative molecular mass (M(r)) of 28,430, indicating that PSA contains a carbohydrate residue of M(r) 2,351, for a total percentage of carbohydrate of 8.3%. Analysis of PSA by SDS-PAGE, however, showed a M(r) of 32,000 to 33,000, suggesting an overestimation of the molecular weight by the latter technique. The complete primary structure of the PSA carbohydrate chain was determined by NMR spectroscopy in combination with carbohydrate composition analysis. The experimentally determined carbohydrate content of PSA confirms that only one N-glycosylation site is occupied in the protein. The proposed carbohydrate structure is a diantennary N-linked oligosaccharide of the N-acetyllactosamine type, with a sialic acid group at the end of each of the two branches. In addition, our data indicate that approximately 70% of the PSA molecules contain a fucose group in the core chitobiose moiety. The calculated molecular weight of this carbohydrate structure (M(r) 2,351.8) is in excellent agreement with the predicted molecular weight of the carbohydrate group, based on the M(r) 28,430 for PSA measured by ion spray mass spectrometry and M(r) 26,079 calculated from the consensus sequence for the peptide portion of the molecule. ISMS of PSA is thus proposed as a convenient and reliable method of quality control, an indispensible step towards international standardization of this very important tumor marker for detection and monitoring of prostatic diseases, especially prostate cancer. |
Author | Graves, H C Grandbois, K Labrie, F Stamey, T A Poppe, I Bélanger, A van Halbeek, H Huang, L |
Author_xml | – sequence: 1 givenname: A surname: Bélanger fullname: Bélanger, A organization: Laboratory of Molecular Endocrinology, Centre Hospitalier de l'Université Laval Research Center, Quebec, Canada – sequence: 2 givenname: H surname: van Halbeek fullname: van Halbeek, H – sequence: 3 givenname: H C surname: Graves fullname: Graves, H C – sequence: 4 givenname: K surname: Grandbois fullname: Grandbois, K – sequence: 5 givenname: T A surname: Stamey fullname: Stamey, T A – sequence: 6 givenname: L surname: Huang fullname: Huang, L – sequence: 7 givenname: I surname: Poppe fullname: Poppe, I – sequence: 8 givenname: F surname: Labrie fullname: Labrie, F |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/7479385$$D View this record in MEDLINE/PubMed |
BookMark | eNotkEtPwzAQhH0oKm3hzAnJfyDFj6R2uFUVFKQikIBztfGDGiVOZDuHXvnluNDTrlbf7Ghmjia-9wahG0qWlBB2N4Q-LlldEyZISfgEzU5bUVIuLtE8xm9CMkfYFE1FKWouqxn6eelbo8YWAu4gRgxeYwWh6Q9HHSAZHFMYVRqDwb3FJ4f0dx2MctapzCf3Zfx95kbtTMS2D9hkqGldPHTGp5MOPHY-meAhud5Di9_e11mRzSDoK3RhoY3m-jwX6PPx4WPzVOxet8-b9a5QpRC8kKysLNRGaslqWuYsnFaMW2krYZQUNTDLoOKMEyEbDVCvRO5hVVFaikpRtkC3_3-HsemM3g_BdRCO-3MX7Bd3ImK8 |
CitedBy_id | crossref_primary_10_1038_srep22050 crossref_primary_10_1016_S0090_4295_96_00616_4 crossref_primary_10_1016_j_cca_2010_08_009 crossref_primary_10_1016_S0022_5347_01_64289_7 crossref_primary_10_1080_00032719_2014_928884 crossref_primary_10_1007_s10719_012_9428_8 crossref_primary_10_1016_j_cca_2024_119689 crossref_primary_10_1021_ja8028137 crossref_primary_10_1002_pros_2990270404 crossref_primary_10_1093_clinchem_46_4_474 crossref_primary_10_2478_v10011_008_0010_7 crossref_primary_10_1080_20014091084236 crossref_primary_10_1515_cclm_1997_35_9_693 crossref_primary_10_1080_00313029800169615 crossref_primary_10_1038_sj_pcan_4500965 crossref_primary_10_1007_s00216_008_2370_8 crossref_primary_10_3109_1354750X_2012_719035 crossref_primary_10_18632_oncotarget_10987 crossref_primary_10_1080_03008880510030941 crossref_primary_10_1093_clinchem_47_4_703 crossref_primary_10_1158_1541_7786_257_2_5 crossref_primary_10_1097_00005392_199705000_00062 crossref_primary_10_1016_0090_4295_95_80001_8 crossref_primary_10_1016_j_ijbiomac_2016_01_110 crossref_primary_10_3923_pjbs_2007_1496_1500 crossref_primary_10_18632_oncotarget_20299 crossref_primary_10_1515_CCLM_2008_129 crossref_primary_10_1016_S0923_2532_01_80043_0 crossref_primary_10_1002_pros_10085 crossref_primary_10_1016_j_neo_2017_07_008 crossref_primary_10_1016_S0923_2532_97_85337_9 crossref_primary_10_1016_j_jprot_2011_06_008 crossref_primary_10_1016_j_clinbiochem_2004_10_016 crossref_primary_10_2298_ABS0602077K crossref_primary_10_1038_s41598_020_59622_y crossref_primary_10_3389_fonc_2021_809170 crossref_primary_10_1016_S0094_0143_05_70370_0 crossref_primary_10_1021_ac203440c crossref_primary_10_1093_glycob_cwm117 crossref_primary_10_1155_2013_923819 crossref_primary_10_1016_S0304_4165_00_00182_3 crossref_primary_10_1002_pmic_201500554 crossref_primary_10_1016_S0009_8981_96_06437_6 crossref_primary_10_1016_j_canep_2018_03_009 crossref_primary_10_1016_S0378_4347_01_00245_6 crossref_primary_10_1002_ijc_33517 crossref_primary_10_1093_glycob_cwp197 crossref_primary_10_1371_journal_pone_0065016 crossref_primary_10_1016_j_ab_2005_01_043 crossref_primary_10_1515_jomb_2017_0024 crossref_primary_10_1517_17530050903266830 crossref_primary_10_1002__SICI_1098_2825_1998_12_1_65__AID_JCLA11_3_0_CO_2_M crossref_primary_10_2478_v10011_007_0041_5 crossref_primary_10_1016_S0009_9120_98_00055_1 crossref_primary_10_1080_07853890903156468 crossref_primary_10_1021_ac5024588 crossref_primary_10_1080_00032719_2016_1161047 crossref_primary_10_1080_10408369891234219 crossref_primary_10_1158_0008_5472_CAN_03_2025 crossref_primary_10_1515_CCLM_2008_145 crossref_primary_10_1111_j_1470_8744_1998_tb00502_x crossref_primary_10_1016_S0022_5347_01_64851_1 crossref_primary_10_1002_pros_10256 crossref_primary_10_1039_C5AN00364D crossref_primary_10_1021_pr400999y crossref_primary_10_1021_a1960021u crossref_primary_10_1016_j_clinbiochem_2004_09_022 crossref_primary_10_1016_S0090_4295_99_80076_4 crossref_primary_10_1021_ac503735e crossref_primary_10_1093_clinchem_48_12_2187 crossref_primary_10_1007_s10735_005_5784_z crossref_primary_10_1039_D3CB00010A crossref_primary_10_1002__SICI_1097_0045_19980801_36_3_181__AID_PROS6_3_0_CO_2_K crossref_primary_10_1006_prep_2000_1342 crossref_primary_10_1021_ac0709955 crossref_primary_10_1016_S0022_5347_01_64704_9 crossref_primary_10_1046_j_1432_1327_2001_02367_x crossref_primary_10_1039_C4LC00464G crossref_primary_10_1016_j_aca_2016_06_043 crossref_primary_10_1093_glycob_cwj042 crossref_primary_10_1002_pro_5560070205 crossref_primary_10_1093_clinchem_46_9_1310 crossref_primary_10_1021_ja037988s crossref_primary_10_1016_j_bbrc_2014_04_107 crossref_primary_10_1016_S0094_0143_05_70372_4 crossref_primary_10_1177_1010428319827223 crossref_primary_10_1002_pros_20751 crossref_primary_10_1021_pr8007545 crossref_primary_10_1093_clinchem_45_4_486 crossref_primary_10_1007_s12038_008_0037_4 crossref_primary_10_1097_00005392_199710000_00085 crossref_primary_10_1016_S1479_666X_05_80048_4 crossref_primary_10_1021_pr8007539 crossref_primary_10_1093_clinchem_43_2_279 crossref_primary_10_1016_j_clinbiochem_2011_11_018 crossref_primary_10_1016_S0378_4347_99_00069_9 crossref_primary_10_3389_fchem_2019_00147 crossref_primary_10_1016_S0338_9898_99_80317_5 crossref_primary_10_1111_j_1464_410X_1997_tb00801_x crossref_primary_10_1007_s00580_014_1910_1 crossref_primary_10_1016_j_cca_2012_06_007 crossref_primary_10_1515_CCLM_1998_120 crossref_primary_10_1002_pro_5560050505 crossref_primary_10_1016_j_tvjl_2008_07_012 crossref_primary_10_1002_pros_20089 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1002/pros.2990270403 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 7479385 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NCRR NIH HHS grantid: P41-RR-05351 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CGR CS3 CUY CVF D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS ECM EIF EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB NPM O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XV2 ZGI ZXP ZZTAW ~IA ~WT |
ID | FETCH-LOGICAL-c4773-8245fa9e8d8291400131523f8f57ec879a2f2a5323078bdaa9677046511475c12 |
ISSN | 0270-4137 |
IngestDate | Sat Sep 28 08:36:05 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4773-8245fa9e8d8291400131523f8f57ec879a2f2a5323078bdaa9677046511475c12 |
PMID | 7479385 |
ParticipantIDs | pubmed_primary_7479385 |
PublicationCentury | 1900 |
PublicationDate | October 1995 |
PublicationDateYYYYMMDD | 1995-10-01 |
PublicationDate_xml | – month: 10 year: 1995 text: October 1995 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Prostate |
PublicationTitleAlternate | Prostate |
PublicationYear | 1995 |
SSID | ssj0010002 |
Score | 1.881195 |
Snippet | Despite the widely accepted use of prostate specific antigen (PSA) as a marker of prostate cancer, this molecule has not yet been completely characterized.... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 187 |
SubjectTerms | Amino Acid Sequence Biomarkers, Tumor - analysis Carbohydrate Sequence Carbohydrates - analysis Carbohydrates - chemistry Electrophoresis, Polyacrylamide Gel Humans Magnetic Resonance Spectroscopy Male Mass Spectrometry Molecular Sequence Data Molecular Weight Oligosaccharides - analysis Oligosaccharides - chemistry Prostate-Specific Antigen - analysis Prostate-Specific Antigen - chemistry Prostatic Neoplasms - chemistry Prostatic Neoplasms - diagnosis Reference Standards Reproducibility of Results |
Title | Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard |
URI | https://www.ncbi.nlm.nih.gov/pubmed/7479385 |
Volume | 27 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELW2VKBeEAUqPisfeqtSEseObW4VAlZUrSrRSr1VdmwLiTZbwXKAI_-B_8uM7WSzW4qgl2hlZ70bz_N4PJl5Q8iOUMGCDgwFrDZfcMabwgRYj0F47YxsSm0i2-dRMz3lH87E2WTyaxS19G1u99off8wruY1UoQ3kilmy_yHZYVBogM8gX7iChOH6TzI-7Gvb7l6CDZxS1MwXO_v03SEDxG4ih8VXBBjXjPkdsRVLzofI0zpHLk50CnxN4YSJABxui76pIU6gi6wSC8fh8cf9wQcxtm4Rc8f5Z4ZzfnoVfxHzi5ecp5g5NTUX1vvPS1kS77EiUoTXdOHDhcbO2VliRDhY-Cpi7ncf9darNCbLArZNOda_iRsg44yPlGmVtuJrSj6RxuKs7eFmCmPyyJMwH4n86jLKXKLjMNUE-mvnCud27lkja1Kh8jxCF1BfFqOMgazDo_R8USV7tfKXNsjdPNDKmSXaLicPyP186KD7CUGbZOK7h-TeYQ6reER-DkCiCCQKU03HQKIDkOgs0B5ItAcSzUB6TTOMKMCILsEIv2c6ugQjCjCiPYwek9N3b0_eTItcnKNouZR1oRgXwWivnGIaTunI2yRYHVQQ0rdKasMCM6LGRANlnTG6kTArDRj4XIq2YlvkTjfr_BNCK6FKXbdVWwXPwaK2VnAtXa1L50zZuKdkK83e-VViYDnP0_rspo7nZGMBvxdkPcCC9y_Bepzb7SjN35mDcEg |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+mass+and+carbohydrate+structure+of+prostate+specific+antigen%3A+studies+for+establishment+of+an+international+PSA+standard&rft.jtitle=The+Prostate&rft.au=B%C3%A9langer%2C+A&rft.au=van+Halbeek%2C+H&rft.au=Graves%2C+H+C&rft.au=Grandbois%2C+K&rft.date=1995-10-01&rft.issn=0270-4137&rft.volume=27&rft.issue=4&rft.spage=187&rft_id=info:doi/10.1002%2Fpros.2990270403&rft_id=info%3Apmid%2F7479385&rft_id=info%3Apmid%2F7479385&rft.externalDocID=7479385 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-4137&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-4137&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-4137&client=summon |